Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Canina pharma GmbH is a specialized German pharmaceutical company focused on the development and manufacture of supplementary feed and care products for pets. Founded in 1984, the company was a pioneer in offering veterinary supplements through pharmacies and has since expanded its portfolio to over 150 products for dogs, cats, horses, and other animals. Their product range includes specialized solutions for joint health, skin and coat care, and metabolic support, often developed in collaboration with veterinarians and biologists. Canina operates its own manufacturing facility in Hamm, Germany, ensuring high-quality standards for its international distribution network. The company is recognized as a market leader in the European pet supplement sector, particularly for its Petvital and Caniviton product lines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Canina.